ProShare Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.61M | Sell |
|
|||||
|
2025
Q2 | $1.11M | Sell |
|
|||||
|
2025
Q1 | $1.41M | Sell |
|
|||||
|
2024
Q4 | $2.04M | Buy |
|
|||||
|
2024
Q3 | $1.78M | Buy |
|
|||||
|
2024
Q2 | $1.44M | Sell |
|
|||||
|
2024
Q1 | $2.04M | Buy |
|
|||||
|
2023
Q4 | $1.99M | Buy |
|
|||||
|
2023
Q3 | $604K | Sell |
|
|||||
|
2023
Q2 | $678K | Buy |
|
|||||
|
2023
Q1 | $662K | Sell |
|
|||||
|
2022
Q4 | $969K | Buy |
|
|||||
|
2022
Q3 | $947K | Buy |
|
|||||
|
2022
Q2 | $721K | Sell |
|
|||||
|
2022
Q1 | $979K | Sell |
|
|||||
|
2021
Q4 | $1.45M | Buy |
|
|||||
|
2021
Q3 | $1.08M | Sell |
|
|||||
|
2021
Q2 | $643K | Buy |
|
|||||
|
2021
Q1 | $691K | Buy |
|
|||||
|
2020
Q4 | $561K | Buy |
|
|||||
|
2020
Q3 | $450K | Buy |
|
|||||
|
2020
Q2 | $427K | Buy |
|
|||||
|
2020
Q1 | $146K | Sell |
|
|||||
|
2019
Q4 | $233K | Sell |
|
|||||
|
2019
Q3 | $270K | Buy |
|
|||||
|
2019
Q2 | $263K | Sell |
|
|||||
|
2019
Q1 | $204K | Buy |
|
|||||
|
2018
Q4 | $157K | Sell |
|
|||||
|
2018
Q3 | $288K | Sell |
|
|||||
|
2018
Q2 | $253K | Sell |
|
|||||
|
2018
Q1 | $229K | Sell |
|
|||||
|
2017
Q4 | $299K | Buy |
|
|||||
|
2017
Q3 | $494K | Buy |
|
|||||
|
2017
Q2 | $333K | Buy |
|
|||||
|
2017
Q1 | $329K | Sell |
|
|||||
|
2016
Q4 | $391K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $48K | Sell |
|
|||||
|
2014
Q2 | $80K | Sell |
|
|||||
|
2014
Q1 | $296K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $128K | Buy |
|